FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2799423193> ?p ?o ?g. }

• W2799423193 endingPage "1131" @default.
• W2799423193 startingPage "1121" @default.
• W2799423193 abstract "The nucleotide substitution G1896A on the precore (pc) region has been implicated in virological and serological responses during treatment in hepatitis B virus (HBV)-infected patients. Whether this mutation affects the therapeutic course of HIV-HBV co-infected patients, especially from Western Africa, is unknown. In this prospective cohort study, 86 antiretroviral (ARV)-naïve HIV-HBV co-infected patients from Côte d'Ivoire, initiating ARV-treatment containing lamivudine (n = 53) or tenofovir (n = 33), had available baseline pc sequences. Association of the pcG1896A mutation with time to undetectable HBV-DNA, hepatitis B e antigen (HBeAg) seroclearance (in HBeAg-positive patients), and hepatitis B surface antigen (HBsAg) seroclearance was evaluated using Cox proportional hazards regression. At ARV-initiation, median HBV-DNA was 6.04 log10 copies/mL (IQR = 3.70-7.93) with 97.7% harbouring HBV genotype E. Baseline pcG1896A mutation was identified in 51 (59.3%) patients, who were more commonly HBeAg-negative (P < .001) and had basal core promotor A1762T/G1764A mutations (P < .001). Patients were followed for a median 36 months (IQR = 24-36). Cumulative proportion of undetectable HBV-DNA was significantly higher in patients with baseline mutation (pcG1896A = 86.6% vs no pcG1896A = 66.9%, P = .04), but not after adjusting for baseline HBV-DNA levels and anti-HBV agent (P = .2). No difference in cumulative proportion of HBeAg seroclearance was observed between mutation groups (pcG1896A = 57.1% vs no pcG1896A = 54.3%, P = .7). Significantly higher cumulative proportion of HBsAg seroclearance was observed in patients without this mutation (pcG1896A = 0% vs no pcG1896A = 36.9%, P < .001), even after adjusting for baseline HBsAg quantification and anti-HBV agent (P < .001). In conclusion, lacking the pcG1896A mutation before ARV initiation appeared to increase HBsAg seroclearance rates during treatment. The therapeutic implications of this mutation need further exploration in this setting." @default.
• W2799423193 created "2018-05-17" @default.
• W2799423193 creator A5006121816 @default.
• W2799423193 creator A5008312486 @default.
• W2799423193 creator A5022180654 @default.
• W2799423193 creator A5024120430 @default.
• W2799423193 creator A5026085361 @default.
• W2799423193 creator A5029970503 @default.
• W2799423193 creator A5030341745 @default.
• W2799423193 creator A5046344019 @default.
• W2799423193 creator A5049211238 @default.
• W2799423193 creator A5063172143 @default.
• W2799423193 creator A5070585467 @default.
• W2799423193 creator A5072327252 @default.
• W2799423193 creator A5080777050 @default.
• W2799423193 date "2018-05-09" @default.
• W2799423193 modified "2023-10-16" @default.
• W2799423193 title "<i>Precore</i> G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa" @default.
• W2799423193 cites W1972734309 @default.
• W2799423193 cites W1978091752 @default.
• W2799423193 cites W1984711089 @default.
• W2799423193 cites W1990405802 @default.
• W2799423193 cites W2012824806 @default.
• W2799423193 cites W2017386225 @default.
• W2799423193 cites W2022484447 @default.
• W2799423193 cites W2026179924 @default.
• W2799423193 cites W2031679656 @default.
• W2799423193 cites W2040280766 @default.
• W2799423193 cites W2049211538 @default.
• W2799423193 cites W2055457987 @default.
• W2799423193 cites W2061410186 @default.
• W2799423193 cites W2061734351 @default.
• W2799423193 cites W2066515493 @default.
• W2799423193 cites W2070410179 @default.
• W2799423193 cites W2078422140 @default.
• W2799423193 cites W2092247428 @default.
• W2799423193 cites W2099591808 @default.
• W2799423193 cites W2129630483 @default.
• W2799423193 cites W2137040136 @default.
• W2799423193 cites W2139126323 @default.
• W2799423193 cites W2141332320 @default.
• W2799423193 cites W2145176834 @default.
• W2799423193 cites W2152100383 @default.
• W2799423193 cites W2152207030 @default.
• W2799423193 cites W2153496188 @default.
• W2799423193 cites W2156398850 @default.
• W2799423193 cites W2161287286 @default.
• W2799423193 cites W2162821279 @default.
• W2799423193 cites W2164445538 @default.
• W2799423193 cites W2167185739 @default.
• W2799423193 cites W2173007581 @default.
• W2799423193 cites W2300592243 @default.
• W2799423193 cites W2329458762 @default.
• W2799423193 cites W2336184200 @default.
• W2799423193 cites W2336207928 @default.
• W2799423193 cites W2492531965 @default.
• W2799423193 cites W2516268278 @default.
• W2799423193 cites W2605175766 @default.
• W2799423193 cites W2605785536 @default.
• W2799423193 cites W2736767329 @default.
• W2799423193 cites W2769552529 @default.
• W2799423193 cites W2794868160 @default.
• W2799423193 cites W3150298192 @default.
• W2799423193 cites W650409306 @default.
• W2799423193 doi "https://doi.org/10.1111/jvh.12914" @default.
• W2799423193 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29660214" @default.
• W2799423193 hasPublicationYear "2018" @default.
• W2799423193 type Work @default.
• W2799423193 sameAs 2799423193 @default.
• W2799423193 citedByCount "7" @default.
• W2799423193 countsByYear W27994231932019 @default.
• W2799423193 countsByYear W27994231932020 @default.
• W2799423193 countsByYear W27994231932021 @default.
• W2799423193 countsByYear W27994231932022 @default.
• W2799423193 crossrefType "journal-article" @default.
• W2799423193 hasAuthorship W2799423193A5006121816 @default.
• W2799423193 hasAuthorship W2799423193A5008312486 @default.
• W2799423193 hasAuthorship W2799423193A5022180654 @default.
• W2799423193 hasAuthorship W2799423193A5024120430 @default.
• W2799423193 hasAuthorship W2799423193A5026085361 @default.
• W2799423193 hasAuthorship W2799423193A5029970503 @default.
• W2799423193 hasAuthorship W2799423193A5030341745 @default.
• W2799423193 hasAuthorship W2799423193A5046344019 @default.
• W2799423193 hasAuthorship W2799423193A5049211238 @default.
• W2799423193 hasAuthorship W2799423193A5063172143 @default.
• W2799423193 hasAuthorship W2799423193A5070585467 @default.
• W2799423193 hasAuthorship W2799423193A5072327252 @default.
• W2799423193 hasAuthorship W2799423193A5080777050 @default.
• W2799423193 hasBestOaLocation W27994231932 @default.
• W2799423193 hasConcept C104317684 @default.
• W2799423193 hasConcept C126322002 @default.
• W2799423193 hasConcept C135763542 @default.
• W2799423193 hasConcept C142462285 @default.
• W2799423193 hasConcept C159047783 @default.
• W2799423193 hasConcept C203014093 @default.
• W2799423193 hasConcept C2522874641 @default.
• W2799423193 hasConcept C2775940106 @default.
• W2799423193 hasConcept C2777382497 @default.

• next